DPY19L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.64457336637724E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.23543406008275E-12 |
Normal-vs-Stage2 |
1.69826999999456E-05 |
Normal-vs-Stage3 |
9.53040000251093E-08 |
Normal-vs-Stage4 |
8.00089999808407E-08 |
Stage1-vs-Stage2 |
4.300600E-01 |
Stage1-vs-Stage3 |
8.769400E-01 |
Stage1-vs-Stage4 |
2.806400E-01 |
Stage2-vs-Stage3 |
4.104200E-01 |
Stage2-vs-Stage4 |
9.243400E-01 |
Stage3-vs-Stage4 |
2.959400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.88657986402541E-15 |
Normal-vs-AfricanAmerican |
9.119000E-03 |
Normal-vs-Asian |
4.745900E-02 |
Caucasian-vs-AfricanAmerican |
2.845300E-04 |
Caucasian-vs-Asian |
1.567180E-01 |
AfricanAmerican-vs-Asian |
1.199760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.88578058618805E-15 |
Normal-vs-Female |
1.63589997104197E-09 |
Male-vs-Female |
1.521810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.316400E-03 |
Normal-vs-Age(41-60Yrs) |
1.74971148680925E-12 |
Normal-vs-Age(61-80Yrs) |
2.06934469559883E-12 |
Normal-vs-Age(81-100Yrs) |
1.808480E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.852200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.650600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.330230E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.858400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.128400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.030100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.250360E-02 |
Normal-vs-Grade 2 |
1.36113342819044E-13 |
Normal-vs-Grade 3 |
2.27419971743359E-10 |
Normal-vs-Grade 4 |
1.68119999999217E-06 |
Grade 1-vs-Grade 2 |
8.157000E-01 |
Grade 1-vs-Grade 3 |
7.082200E-01 |
Grade 1-vs-Grade 4 |
7.021400E-01 |
Grade 2-vs-Grade 3 |
8.725600E-02 |
Grade 2-vs-Grade 4 |
6.275200E-01 |
Grade 3-vs-Grade 4 |
1.673170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.02295949488962E-12 |
Normal-vs-ccB subtype |
5.26578780579712E-13 |
ccA subtype-vs-ccB subtype |
1.493980E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.44391182238724E-13 |
Normal-vs-N1 |
1.101580E-02 |
N0-vs-N1 |
3.502200E-01 |
|
|